Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Pilot bioavailability testing of CDT extended release ondansetron tablets

Feb. 21, 2006

Targeting gamma-secretase provides neuroprotection in preclinical stroke

Feb. 21, 2006

NNZ-4921 shows promise in rat peripheral neuropathy model

Feb. 21, 2006

17beta-Estradiol targets STAT3 to provide neuroprotection following stroke

Feb. 21, 2006

Initial preclinical data for ReN-004 stem cell lines for Parkinson's disease

Feb. 21, 2006

Tadalafil improves neurological function in a preclinical stroke model

Feb. 21, 2006

Bryostatin 1 provides protection against ischemia/reperfusion injury

Feb. 21, 2006

Neuroprotective action of a HIF prolyl hydroxylase inhibitor may be beneficial in stroke

Feb. 20, 2006

Recent patents cover novel treatments for anxiety, depression, psychosis, etc.

Feb. 20, 2006

Novel analgesic agents disclosed in recent Vertex patent

Feb. 20, 2006

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...